Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Use the power of over 35 years of data to discover global trends impacting today’s drug development industry.
How it helps
Easily identify opportunities or market saturation with Pharmaprojects. Our expert analysts track new molecular targets entering pipelines, in-and-out licensing activity and conduct primary research on your behalf to uncover additional information around your chosen drug or company. Pharmaprojects links to Trialtrove’s clinical trial intelligence, leveraging the power of both to ensure you stay on top of every clinical trial development for your disease, company, or therapeutic mechanism of interest.
How it works
Pharmaprojects’ intuitive interface supports fast access to drug development results for specific diseases, companies, and countries. These results can appear as graphics-driven analytic dashboards or exportable files.
Quickly tap into Pharmaprojects’ comprehensive data to support your next R&D decision.
Analyst reviewed data and enriched content
Development history, licensing data, searchable molecular structures and more
Get an analysis of drug development trends dating back over 35 years
Unlimited support for your research from experienced industry analysts
Instantly and easily generate custom tables and charts of key trial attributes
Trialtrove, Pharmaprojects
By Laura Runkel 18 Sep 2017
As clinical and diagnostic parameters evolve over time, Trialtrove strives to reflect them in our patient segments and disease coverage.
Topic Clinical trials blog
Pharmaprojects
By Loni Branon 13 Sep 2017
A Look At Prevalence and Current Clinical Trial Activity – Is There More We Could Be Doing?
Topic Clinical trials
Pharmaprojects, Citeline
By Benjamin Graham 23 Aug 2017
Since its discovery in 1976 near the Ebola river in the Democratic Republic of the Congo, Ebola virus has stalked Africa, sporadically reappearing from its suspected (but yet unknown) animal reservoir.
Topic Ebola
Pharmaprojects
By Hannah Sally 24 Jul 2017
Thirty-five drugs are presently available in multiple global markets for Parkinson’s disease (PD) patients.
Topic Parkinsons disease
Pharmaprojects, Trialtrove
By Jake Mathon 28 Jun 2017
Pharma companies have repurposed drugs into single pill combinations for years.
Topic Diabetes
Pharmaprojects
12 Jun 2017
This informative visual gives you a snapshot view of the current dyslipidemia market and the drugs poised to challenge the unparalleled reign of statins.
Topic Dyslipidaemia
Pharmaprojects
17 May 2017
We will discuss the industry trends by examining the pipeline by company, therapeutic area, disease, target and drug type, using data from Pharma Intelligence’s Phamaprojects.
Topic Research
Pharmaprojects, Sitetrove, Trialtrove
19 Apr 2017
The R&D Annual Review webinar is happening soon. Take a look back at pharma R&D in 2016 and look ahead to the remainder of the year to get expert insight from the senior experts at Pharma Intelligence during this free webinar.
Pharmaprojects
By Ian Lloyd 13 Apr 2017
Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2017, this supplement takes a look at the industry’s success stories of 2016 – the drugs which were launched on to the market for the first time during the year.
Pharmaprojects
22 Mar 2017
With the recent controversy surrounding the approval and launch of the first wave of PCSK9 inhibitors (focussing mainly on the extremely high cost in comparison to statin therapies), it may be easy to forget that the dyslipidaemia space has also been plagued by a number of high profile and costly failures too.
Pharmaprojects
By Ian Lloyd 22 Mar 2017
Thank you for your interest in the latest report from Pharmaprojects, Pharma R&D Annual Review 2017.
Topic Research
Pharmaprojects
By Ian Lloyd 22 Mar 2017
Welcome to Pharmaprojects' 2017 review of trends in pharmaceutical R&D.
Pharmaprojects, Biomedtracker, Trialtrove
By Rachel Meighan-Mantha 22 Mar 2017
The field of epigenetics is rapidly expanding and as interest continues to grow, epigenetics has become an increasingly promising area for research.
Pharmaprojects
27 Feb 2017
Over 350 million people worldwide are suffering from rare diseases. Which is why it is necessary to understand the rare disease landscape to date.
Pharmaprojects
By Doro Shin 25 Jan 2016
On April 27, 2016, Informa will host its inaugural Clinical and Research Excellence (CARE) Awards to honor those in clinical R&D who are making a difference and committed to making human lives better.
Karen specializes in
+28 year(s) experience
Patricia specializes in
+26 year(s) experience
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Approximately 400,000 investigators in over 170 countries, all with clinical trial experience, all at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove, now on a sleek, modern interface for simpler, faster and more efficient searching.
To build and maintain gold-standard, next generation R&D intelligence tools, Sitetrove, Trialtrove, Chinatrove, Pharmaprojects, and Trialpredict have been undergoing a major program of investment. In addition to the many new and exciting changes on the horizon, the robust and reliable Citeline tools that you use to inform your business decisions will formally join Informa’s Pharma Intelligence family of brands.
Looking for more products Product Finder
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
